n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine has been researched along with ursolic acid in 1 studies
| Studies (n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine) | Trials (n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine) | Recent Studies (post-2010) (n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine) | Studies (ursolic acid) | Trials (ursolic acid) | Recent Studies (post-2010) (ursolic acid) |
|---|---|---|---|---|---|
| 79 | 1 | 16 | 1,577 | 10 | 1,083 |
| Protein | Taxonomy | n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine (IC50) | ursolic acid (IC50) |
|---|---|---|---|
| Aldo-keto reductase family 1 member B10 | Homo sapiens (human) | 4 | |
| Glycogen phosphorylase, muscle form | Oryctolagus cuniculus (rabbit) | 8.9708 | |
| Basic phospholipase A2 1 | Naja melanoleuca (forest cobra) | 2.9 | |
| DNA polymerase beta | Rattus norvegicus (Norway rat) | 6.65 | |
| Neutrophil elastase | Homo sapiens (human) | 0.416 | |
| Receptor-type tyrosine-protein phosphatase F | Homo sapiens (human) | 3.8 | |
| Tyrosine-protein phosphatase non-receptor type 2 | Homo sapiens (human) | 4.1433 | |
| Tyrosine-protein phosphatase non-receptor type 1 | Homo sapiens (human) | 3.8872 | |
| Liver carboxylesterase 1 | Homo sapiens (human) | 0.1 | |
| Low molecular weight phosphotyrosine protein phosphatase | Homo sapiens (human) | 7.2 | |
| Corticosteroid 11-beta-dehydrogenase isozyme 1 | Homo sapiens (human) | 1.9 | |
| Delta-type opioid receptor | Mus musculus (house mouse) | 3.6 | |
| Nuclear receptor ROR-gamma | Homo sapiens (human) | 3.5333 | |
| Basic phospholipase A2 PLA-A | Protobothrops flavoviridis | 2.5 | |
| Transcription factor p65 | Homo sapiens (human) | 0.031 | |
| Acidic phospholipase A2 EC-I | Echis carinatus (saw-scaled viper) | 2.3 | |
| Ubiquitin carboxyl-terminal hydrolase 7 | Homo sapiens (human) | 7 | |
| Sentrin-specific protease 1 | Homo sapiens (human) | 1.2932 | |
| Protease | Human immunodeficiency virus 1 | 8 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Batista-Gonzalez, A; Brunhofer, G; Fallarero, A; Gopi Mohan, C; Karlsson, D; Shinde, P; Vuorela, P | 1 |
1 other study(ies) available for n-(n-(3-carboxyoxirane-2-carbonyl)leucyl)isoamylamine and ursolic acid
| Article | Year |
|---|---|
Exploration of natural compounds as sources of new bifunctional scaffolds targeting cholinesterases and beta amyloid aggregation: the case of chelerythrine.
Topics: Acetylcholinesterase; Amyloid beta-Peptides; Benzophenanthridines; Binding Sites; Butyrylcholinesterase; Catalytic Domain; Cholinesterase Inhibitors; Humans; Isoquinolines; Kinetics; Molecular Docking Simulation; Structure-Activity Relationship | 2012 |